Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Case Series of Infants With Anterior Ankyloglossia Being Treated by the Sublingual Neonatal Incision Platform Device

NCT: NCT07655895 · ACTIVE_NOT_RECRUITING

NCT IDNCT07655895
StatusACTIVE_NOT_RECRUITING
Start Date2026-03-10
Completion2026-07-01
SponsorEuropa Life Sciences Limited (INDUSTRY)
First posted
Last updated

Brief Summary

A study assessing the feasibility of a novel device designed specifically to treat infant tongue-tie.

Frequently Asked Questions

What is Case Series of Infants With Anterior Ankyloglossia Being Treated by the Sublingual Neonatal Incision Platform Device?

Case Series of Infants With Anterior Ankyloglossia Being Treated by the Sublingual Neonatal Incision Platform Device is a clinical trial registered under NCT07655895. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT07655895?

The current status of NCT07655895 (Case Series of Infants With Anterior Ankyloglossia Being Treated by the Sublingual Neonatal Incision Platform Device) is: ACTIVE_NOT_RECRUITING.

When did Case Series of Infants With Anterior Ankyloglossia Being Treated by the Sublingual Neonatal Incision Platform Device start?

Case Series of Infants With Anterior Ankyloglossia Being Treated by the Sublingual Neonatal Incision Platform Device started on 2026-03-10.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑